Black Mark Warnings Of FDA On Medicines To Denote Heavy Risks

The drugs from the clinical trial enter the market only after receiving the approval from FDA. Few medicines that come out of the clinical trial put risks on the customers if taken in the heavy dosages. Intake of such medicine may cure few health disorders, but heavy intake of the same drug puts you to possible risks. To caution the end user against such risk, FDA has stamps a black mark on the medicines rather than banding it. Tough the caution given by FDA on the medicine curbed the usage of the medicine. The action taken by the Food Drug Approval agency is not enough to reduce the possible risks of the medicine in the market. 

Public takes the drug approved by FDA with greater assurance. More innovative steps are required from FDA to caution the public against the risk of heavy intake of the drugs that have stamped the black mark.